Bilateral germ cell testicular tumors in New Zealand: Experience in Auckland and Christchurch 1978-1994

Journal of Clinical Oncology

Volumn 14, Issue 7, 1996, Pages 2061-2065

  Colls, B M ^a   Harvey, V J ^a   Skelton, L ^a   Thompson, P I ^a   Frampton, C M ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; SECOND CANCER; SEMINOMA; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

EID: 0030014430     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.7.2061     Document Type: Article

References (20)

1. Bidard M: Cancer du Testicule. Bull Soc Anat 28:345, 1853
2. Sokal M, Peckham MJ, Hendry WF: Bilateral germ cell tumours of the testis. Br J Urol 52:158-162, 1980
3. Hoekstra HJ, Sleyfer DT, Wobbes T, et al: Bilateral primary germ cell tumours of testis. Urology 19:152-154, 1982
4. Ware SM, Heyman J, Al-Askari S, et al: Bilateral testicular germ cell malignancy. Urology 19:366-372, 1982
5. Kristianslund S, Fossa SD, Kjellevold K: Bilateral malignant testicular germ cell cancer. Br J Urol 58:60-63, 1986
6. Dieckmann K-P, Boeckmann W, Brosig W, et al: Bilateral testicular germ cell tumours. Cancer 57:1254-1258, 1986
7. Scheiber K, Ackermann D, Studer UE: Bilateral testicular germ cell tumours: A report of 20 cases. J Urol 138:73-76, 1987
8. Thompson J, Williams CJ, Whitehouse JMA, et al: Bilateral testicular germ cell tumours: An increasing incidence and prevention by chemotherapy. Br J Urol 62:374-376, 1988
9. Osterlind A, Berthelsen JG, Abildgaard N, et al: Risk of bilateral testicular germ cell cancer in Denmark: 1960-1984. J Natl Cancer Inst 83:1391-1395, 1991
10. Nicolai N, Pizzocaro G, Salvioni R, et al: Bilateral germ cell tumours of the testis (BGCTT): Int experience. Eur J Cancer 27:109, 1991 (suppl 2, abstr 640)
11. Bokemeyer C, Schmoll H-J, Schoffski P, et al: Bilateral testicular tumours: Prevalence and clinical implications. Eur J Cancer 29A:874-876, 1993
12. Pearce N, Sheppard RA, Howard JK, et al: Time trends and occupational differences in cancer of the testis in New Zealand. Cancer 59:1677-1682, 1987
13. Travis LB, Curtis RE, Hankey BF: Second malignancies after testicular cancer. J Clin Oncol 13:533-534, 1995 (letter)
14. Einhorn LH, Williams SD, Loehrer PJ, et al: Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumours: A Southeastern Cancer Study Group protocol. J Clin Oncol 7:387-391, 1989
15. Senturia YD: The epidemiology of testicular cancer. Br J Urol 60:285-291, 1987
16. Peckham MJ: Investigation and staging: General aspects and staging classification, in Peckham M (ed): The Management of Testicular Tumours. London, United Kingdom, Edward Arnold, 1981, chapt 7, p 89-101
17. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35:1-39, 1977
18. Fossa SD, Aass N: Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer. Br J Urol 63:531-534, 1989
19. Boshoff C, Rustin G, Begent R, et al: Treatment of good-risk, stage II, non-seminomatous testis cancer. Lancet 344:1085-1086, 1994
20. Von der Maase H, Meinecke B, Skakkebaek NE: Residual carcinoma-in-situ of contralateral testis after chemotherapy. Lancet 1:477-478, 1988